Evidence map›Paper›PMID 40082617›Full record

ArticleNature neuroscience2025

Sympathetic and parasympathetic subtypes of body-first Lewy body disease observed in postmortem tissue from prediagnostic individuals.

Katrine B Andersen, Anushree Krishnamurthy, Mie Kristine Just, Nathalie Van Den Berge, Casper Skjærbæk, Jacob Horsager, Karoline Knudsen, Jacob W Vogel, Jon B Toledo, Johannes Attems and 4 more

Abstract read
In one paragraph

Article in Nature neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Spatiotemporal Progression Patterns of Striatal Dopamine Depletion and Cerebral Hypoperfusion in Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2026
    Article
  4. Review
  5. Gray Matter Microstructure Measured Using Diffusion Imaging as a Biomarker of Severity in Lewy Body Diseases.Movement disorders : official journal of the Movement Disorder Society · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The Noradrenergic Brain in Parkinson's Disease.Current neurology and neuroscience reports · 2026
    Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Katrine B Andersen *Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0000-0003-0015-2170
Anushree Krishnamurthy *Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0000-0002-4512-5996
Mie Kristine JustDepartment of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Nathalie Van Den BergeDepartment of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Casper SkjærbækDepartment of Clinical Medicine, Aarhus University, Aarhus, Denmark.ORCID http://orcid.org/0000-0003-2823-8785
Jacob HorsagerDepartment of Nuclear Medicine and PET, Aarhus University Hospital, Aarhus, Denmark.
Karoline KnudsenDepartment of Nuclear Medicine and PET, Aarhus University Hospital, Aarhus, Denmark.
Jacob W VogelDepartment of Clinical Sciences Malmö, Faculty of Medicine, SciLifLab, Lund University, Lund, Sweden.ORCID http://orcid.org/0000-0001-6394-9940
Jon B ToledoStanley Appel Department of Neurology, Houston Methodist, Weill Cornell Medical College, Houston, TX, USA.ORCID http://orcid.org/0000-0003-4366-9268
Johannes AttemsTranslational and Clinical Research Institute, Campus for Ageing and Vitality, Newcastle upon Tyne, UK.
Tuomo PolvikoskiCellular Pathology Department, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
Yuko SaitoBrain Bank for Aging Research, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo, Japan.
Shigeo MurayamaBrain Bank for Aging Research, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo, Japan.
Per BorghammerDepartment of Clinical Medicine, Aarhus University, Aarhus, Denmark. borghammer@clin.au.dk.ORCID http://orcid.org/0000-0001-6391-8052

Funding

Jascha Fonden (Jascha Foundation) NoneLundbeckfonden (Lundbeck Foundation) R359-2020-2533MEXT | Japan Society for the Promotion of Science (JSPS) JP22H04923Parkinsonforeningen (Danish Parkinson Association) A901Science for Life Laboratory (SciLifeLab) KAW 2020.0239Sundhed og Sygdom, Det Frie Forskningsråd (Medical Sciences, Danish Council for Independent Research) 3165-00212ATokyo Metropolitan University (Tokyo Toritsu Daigaku) JP21wm0425019
6 · The paper itself

Abstract

Recent studies suggest the existence of brain-first and body-first subtypes within the Lewy body disorder (LBD) spectrum, including Parkinson's disease. These studies primarily focused on α-synuclein propagation through the parasympathetic vagal and olfactory bulb routes, leaving the possibility of a sympathetic nervous system spreading route unexplored. In the present study, we analyzed two postmortem datasets, which included 173 and 129 cases positive for Lewy pathology. We observed a clear distinction between brain-first and body-first subtypes in early prediagnostic cases with mild Lewy pathology. Brain-first cases displayed minimal peripheral organ pathology in prediagnostic phases, contrasting with marked autonomic involvement in prediagnostic body-first cases. Utilizing the SuStaIn machine learning algorithm, we identified two distinct body-first subtypes, one with vagal predominance and another with sympathetic predominance, in equal proportions. Our study supports the existence of three prediagnostic LBD subtypes and highlights the sympathetic nervous system alongside the parasympathetic system in LBD onset and progression.

Indexed as

BrainLewy Body DiseaseParasympathetic Nervous SystemSympathetic Nervous SystemAgedAged, 80 and overAutopsyFemaleHumansMaleMiddle AgedParkinson Disease

Identifiers

PMID40082617
PMCPMC12081295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.